150 related articles for article (PubMed ID: 6083584)
21. Monocyte-specific antigens--detection by the antibody-dependent cellular cytotoxicity (ADCC) method.
Johny M; Pazderka F; Kovithavongs T; Schlaut J; Dossetor JB
Transplant Proc; 1979 Dec; 11(4):1970-3. PubMed ID: 93817
[No Abstract] [Full Text] [Related]
22. Antibody-dependent and natural killer cytotoxicity in type 1 diabetes.
Sensi M; Pozzilli P; Cudworth AG
Acta Diabetol Lat; 1981; 18(4):339-44. PubMed ID: 7331674
[TBL] [Abstract][Full Text] [Related]
23. [Acute pyelonephritis and the immunity status].
Vozianov AF; Drannik GN; Petrovskaia IA; Pasechnikov SP; Driianskaia VE; Kushko LIa; Ozvinchuk II; Pshegornitskiĭ IV; Pogrebinskiĭ VM
Vrach Delo; 1991 Apr; (4):26-9. PubMed ID: 1829561
[TBL] [Abstract][Full Text] [Related]
24. [Regulation of immune system functions].
Petrov RV
Arkh Patol; 1983; 45(4):3-11. PubMed ID: 6191742
[No Abstract] [Full Text] [Related]
25. [Immune reactions and vascular complications in diabetes mellitus].
Triolo G
Recenti Prog Med; 1987 Jan; 78(1):36-8. PubMed ID: 3589119
[No Abstract] [Full Text] [Related]
26. The temporal association between gamma delta T cells and the natural history of insulin-dependent diabetes.
Lang FP; Pollock BH; Riley WJ; Maclaren NK; Barrett DJ
J Autoimmun; 1993 Feb; 6(1):107-19. PubMed ID: 8457282
[TBL] [Abstract][Full Text] [Related]
27. Lymphocyte populations and responses to mitogens in infants of diabetic mothers.
El Mohandes A; Touraine JL; Touraine F; Shukry AS; Salle B
J Clin Lab Immunol; 1982 May; 8(1):25-9. PubMed ID: 6212685
[TBL] [Abstract][Full Text] [Related]
28. [Heterogeneity of diabetes mellitus].
Asfandiiarova NS; Kolcheva NG; Shatrova IV
Ter Arkh; 1999; 71(12):49-52. PubMed ID: 10647203
[TBL] [Abstract][Full Text] [Related]
29. [Antibody-dependent cell-mediated cytotoxicity of ADCC].
Descamps B
Ann Immunol (Paris); 1980; 131C(2):127-42. PubMed ID: 6998353
[No Abstract] [Full Text] [Related]
30. Antibody-dependent cell-mediated cytotoxicity and natural killer-cell phenomenon.
Djeu JY
J Am Vet Med Assoc; 1982 Nov; 181(10):1043-8. PubMed ID: 6184352
[No Abstract] [Full Text] [Related]
31. In vitro production of islet cell antibodies from peripheral blood lymphocytes in insulin-dependent diabetics.
Yamaguchi Y; Yokota A; Nakanishi T; Ueda Y; Takahashi A; Kuriya N; Mori T; Toyama K; Akazawa S; Miyake S
J Med Assoc Thai; 1987 Mar; 70 Suppl 2():114-8. PubMed ID: 3598415
[No Abstract] [Full Text] [Related]
32. [Hemolytic plaque cells (plaque forming cells) in patients with type I and type II diabetes mellitus].
Goldoni V; Marotti T; Vrbanec D; Cabrijan T; Zjacić-Rotkvić V; Pavelić K; Sekso M
Acta Med Iugosl; 1986; 40(3):201-6. PubMed ID: 3535390
[No Abstract] [Full Text] [Related]
33. [Functional deficiency of the Fc(IgG) receptor of peripheral blood monocytes in uncompensated diabetes mellitus].
Gómez Rodríguez F; Ruiz Alcantarilla P; Zamora Madaria E
Rev Clin Esp; 1986 Nov; 179(7):343-6. PubMed ID: 3797746
[No Abstract] [Full Text] [Related]
34. [Immunological abnormalities in multiple sclerosis].
Tabira T
No To Shinkei; 1983 Jun; 35(6):535-41. PubMed ID: 6194805
[No Abstract] [Full Text] [Related]
35. [Complement (C3) receptor dependent monocyte recognition in uncompensated diabetes mellitus types I and II].
Gómez Rodríguez F; Ruiz Alcantarilla P; Zamora Madaria E
Rev Clin Esp; 1986 Sep; 179(4):167-71. PubMed ID: 3532232
[No Abstract] [Full Text] [Related]
36. [Diabetes mellitus with intractable bacterial infections].
Sato A; Tamura R; Shirai T
Nihon Rinsho; 1994 Feb; 52(2):389-94. PubMed ID: 8126891
[TBL] [Abstract][Full Text] [Related]
37. Immunity in diabetes mellitus.
Narang NK; Gupta RC; Singh N
J Assoc Physicians India; 1989 Sep; 37(9):614. PubMed ID: 2632568
[No Abstract] [Full Text] [Related]
38. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
39. Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells.
Ault KA; Springer TA
J Immunol; 1981 Jan; 126(1):359-64. PubMed ID: 7451976
[TBL] [Abstract][Full Text] [Related]
40. Circulating CD4+CD25 high regulatory T cells and natural killer T cells in children with newly diagnosed type 1 diabetes or with diabetes-associated autoantibodies.
Oling V; Marttila J; Knip M; Simell O; Ilonen J
Ann N Y Acad Sci; 2007 Jun; 1107():363-72. PubMed ID: 17804564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
